Adding topotecan to standard treatment for ovarian cancer does not improve progression-free survival
Monday, October 11, 2010 - 16:10
in Health & Medicine
Adding topotecan to carboplatin plus paclitaxel, the standard treatment for ovarian cancer, does not improve progression-free survival in patients and leads to greater toxicity, according to a study...